SEC-sourced researchBeta
CAPR
CAPRICOR THERAPEUTICS, INC.
Company comparison ↗
Data passport
- CIK
- 0001133869
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Sep 14, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 22,270,465.0000 | Mar 17, 2026 |
| December 2025 | 0.0000 | Mar 17, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 0.0000 | -105,043,946.0000 | -69,811,261.0000 | 355,949,294.0000 | 50,157,149.0000 | Mar 17, 2026 |
| December 2024 | 22,270,465.0000 | -40,467,186.0000 | -39,995,742.0000 | 170,481,086.0000 | 25,018,750.0000 | Mar 17, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $0 | December 2025 | Mar 17, 2026 | 10-K |
| Previous period revenueRevenues | $22.27M | December 2024 | Mar 17, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$105.04M | December 2025 | Mar 17, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$69.81M | December 2025 | Mar 17, 2026 | 10-K |
| Total assetsAssets | $355.95M | December 2025 | Mar 17, 2026 | 10-K |
| Total liabilitiesLiabilities | $50.16M | December 2025 | Mar 17, 2026 | 10-K |